News Focus
News Focus
icon url

falconer66a

02/28/21 10:54 AM

#301055 RE: Investor2014 #301051

Or, before.

By prompt, I am assuming you mean after a positive readout from the planned P3 PDD trial perhaps some time in 2023?


Others cogent with the multitude of details regarding the conduct of acceptable drug trials can more accurately project when the FDA approves blarcamesine. No matter, the data in the paper be validating and supportive.
icon url

rayovacAAA

02/28/21 11:34 AM

#301059 RE: Investor2014 #301051

AN A2-73 P3 PDD TRIAL WASN'T LISTED ON THE LATEST AVXL CORPORATE PRESENTATION!!!!!!!


By prompt, I am assuming you mean after a positive readout from the planned P3 PDD trial perhaps some time in 2023?




THEREFORE ONCE ALL THE DOTS WERE CONNECTED, APPROVAL MUST BE IMMINENT!!!!